Evidence map›Paper›PMID 41491543›Full record

ArticleJournal of cheminformatics2026

PepGraphormer: an ESM-GAT hybrid deep learning framework for antimicrobial peptide prediction.

Changhang Lin, Shuwen Xiong, Jinjin Li, Feifei Cui, Zilong Zhang, Hua Shi, Leyi Wei

Abstract read
In one paragraph

Article in Journal of cheminformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Changhang LinFaculty of Applied Sciences, Macao Polytechnic University, R. de Luís Gonzaga Gomes, Macao, 999078, China.
Shuwen XiongFaculty of Applied Sciences, Macao Polytechnic University, R. de Luís Gonzaga Gomes, Macao, 999078, China.
Jinjin LiFaculty of Applied Sciences, Macao Polytechnic University, R. de Luís Gonzaga Gomes, Macao, 999078, China.
Feifei CuiSchool of Computer Science and Technology, Hainan University, Haikou, 570228, China.
Zilong ZhangSchool of Computer Science and Technology, Hainan University, Haikou, 570228, China.
Hua ShiSchool of Opto-electronic and Communication Engineering, Xiamen University of Technology, Xiamen, 361024, China.
Leyi WeiFaculty of Applied Sciences, Macao Polytechnic University, R. de Luís Gonzaga Gomes, Macao, 999078, China. weileyi@mpu.edu.mo.

Funding

Internal Research Grants of Macao Polytechnic University no. RP/CAI-02/2023National Natural Science Foundation of China Nos. 62322112the Science and Technology Development Fund no. 0177/2023/RIA3
6 · The paper itself

Abstract

The prediction of Antimicrobial Peptides (AMPs) is a critical research area in drug discovery. Traditional methods, which rely on sequence alignment or handcrafted features, often fail to capture complex sequence-function relationships. Recently, Large Language Models (LLMs) like ESM2 have demonstrated remarkable success in extracting deep semantic features from protein sequences. Meanwhile, Graph Neural Networks (GNNs), particularly Graph Attention Networks (GATs), can effectively learn inter-node relationships, specifically capturing peptide-residue compositional links and inter-residue co-occurrence patterns, to aggregate neighborhood information. In this work, we propose PepGraphormer, a novel fusion model that combines the powers of large-scale pretraining from ESM2 and the structural learning advantages from GATs for AMP prediction. We first construct a heterogeneous graph with peptide sequences and amino acids as nodes, where ESM2 is leveraged to generate high-quality initial embeddings for the peptide sequence nodes. Then the classification fuses the direct predictions from ESM2 and the graph-based predictions from the GAT. The training jointly trains the ESM2 and GAT modules and learns the embeddings for nodes in the graph. Comparisons with current state-of-the-art models on multiple datasets demonstrate that PepGraphormer achieves excellent accuracy and stability in the AMP prediction task. Further ablation and generalization experiments confirm the effectiveness and robustness of this fusion framework, presenting a new avenue for computationally-driven therapeutic peptide discovery.Scientific contribution This work proposes a novel framework PepGraphormer that combines the powers of transformer-based large language model (ESM2) and graph attention network for antimicrobial peptide prediction, without requiring the 3D protein structural information used in previous studies. The model significantly outperforms state-of-the-art methods and various deep learning baselines on multiple AMP benchmark datasets.

Indexed as

Antimicrobial peptideDrug discoveryESM2GATPrediction models

Identifiers

PMID41491543
PMCPMC12870942

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.